Cargando…
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality
BACKGROUND: The economic costs of treating patients with metastatic breast cancer have been examined in several studies, but available estimates of economic burden are at least a decade old. In this study, we characterize healthcare utilization and costs in the US among women with metastatic breast...
Autores principales: | Vera-Llonch, Montserrat, Weycker, Derek, Glass, Andrew, Gao, Sue, Borker, Rohit, Qin, Angie, Oster, Gerry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141771/ https://www.ncbi.nlm.nih.gov/pubmed/21676243 http://dx.doi.org/10.1186/1471-2407-11-250 |
Ejemplares similares
-
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
por: Vera-Llonch, Montserrat, et al.
Publicado: (2011) -
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective
por: Vera-Llonch, Montserrat, et al.
Publicado: (2009) -
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
por: Weycker, Derek, et al.
Publicado: (2014) -
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
por: Amdahl, Jordan, et al.
Publicado: (2020) -
FRI090 Patterns Of Triglyceride Testing And Results Over Time Among Patients With Diabetes And Severe Hypertriglyceridemia In US Clinical Practice
por: Kutrieb, Emily, et al.
Publicado: (2023)